XTL Biopharmaceuticals Ltd ADR (XTLB)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $3.93M
Last updated: Nov 17, 2026 at 4:16 PM ET
XTL Biopharmaceuticals Ltd ADR (XTLB) Stock Chart
XTL Biopharmaceuticals Ltd ADR (XTLB) has a latest price of $1.52 on Nov 17, 2026, 73.0% below its 52-week high of $5.64. Its price fell 58.7% over the past 12 months. The month-end price fell 90.2% over the 10 years through Oct 2026, a compound annual decline of 20.8%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $19.80 in Aug 2021 and its lowest $1.61 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart XTLB with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for XTLB.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 49.0%, and over 6 months it fell 39.9%. The month-end price fell 51.7% over the 3 years through Oct 2026, a compound annual decline of 21.5%.
| Period | Change |
|---|---|
| 1 month | -22.4% |
| 3 months | -49.0% |
| 6 months | -39.9% |
| 12 months | -58.7% |
| 12 months, with dividends | -58.7% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -51.7% | -21.5% |
| 5 years | -89.5% | -36.2% |
| 10 years | -90.2% | -20.8% |
Price by Year
Its best calendar year was 2020, when the price rose 121.2%, and its weakest was 2025, when it fell 71.4%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $1.61 | -30.6% |
| 2025 | $2.32 | -71.4% |
| 2024 | $8.10 | +100.6% |
| 2023 | $4.04 | -16.5% |
| 2022 | $4.84 | -56.3% |
| 2021 | $11.08 | -8.6% |
| 2020 | $12.12 | +121.2% |
| 2019 | $5.48 | -20.8% |
| 2018 | $6.92 | -24.5% |
| 2017 | $9.16 | -27.8% |
Trading Range
The price is 24.4% below its 50-day average of $2.01 and 41.1% below its 200-day average of $2.58.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $1.52 | |
| 52-week high | $5.64 | -73.0% |
| 52-week low | $1.52 | 0.0% |
| 50-day average | $2.01 | -24.4% |
| 200-day average | $2.58 | -41.1% |
Price Risk
Over 3 years, its largest fall from a peak was 88.6%.
| Measure | Value |
|---|---|
| 1-year beta | 0.56 |
| Largest fall, 1 year | -64.5% |
| Largest fall, 3 years | -88.6% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About XTLB
What is XTLB's 1-year price change?
XTL Biopharmaceuticals Ltd ADR's price fell 58.7% over the past 12 months. With dividends included, the 12-month total return was -58.7%.
What is XTLB's 5-year price change?
XTL Biopharmaceuticals Ltd ADR's month-end price fell 89.5% over the 5 years through Oct 2026, a compound annual decline of 36.2%. These figures leave out dividends.
What is XTLB's 52-week high and low?
XTL Biopharmaceuticals Ltd ADR's 52-week high is $5.64 and its 52-week low is $1.52. Its latest price of $1.52 on Nov 17, 2026 is 73.0% below the high.
What is XTLB's beta?
XTL Biopharmaceuticals Ltd ADR's 1-year beta against the S&P 500 is 0.56, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 64.5%.
Is the XTLB chart free?
Yes. Advanced Charting for XTLB is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.